A20 Negatively Regulates T Cell Receptor Signaling to NF-κB by Cleaving Malt1 Ubiquitin Chains
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
The Carma1-Bcl10-Malt1 signaling module bridges TCR signaling to the canonical IκB kinase (IKK)/NF-κB pathway. Covalent attachment of regulatory ubiquitin chains to Malt1 paracaspase directs TCR signaling to IKK activation. Further, the ubiquitin-editing enzyme A20 was recently suggested to suppress T cell activation, but molecular targets for A20 remain elusive. In this paper, we show that A20 regulates the strength and duration of the IKK/NF-κB response upon TCR/CD28 costimulation. By catalyzing the removal of K63-linked ubiquitin chains from Malt1, A20 prevents sustained interaction between ubiquitinated Malt1 and the IKK complex and thus serves as a negative regulator of inducible IKK activity. Upon T cell stimulation, A20 is rapidly removed and paracaspase activity of Malt1 has been suggested to cleave A20. Using antagonistic peptides or reconstitution of Malt1−/− T cells, we show that Malt1 paracaspase activity is required for A20 cleavage and optimal IL-2 production, but dispensable for initial IKK/NF-κB signaling in CD4+ T cells. However, proteasomal inhibition impairs A20 degradation and impedes TCR/CD28-induced IKK activation. Taken together, A20 functions as a Malt1 deubiquitinating enzyme and proteasomal degradation and de novo synthesis of A20 contributes to balance TCR/CD28-induced IKK/NF-κB signaling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“UBASH3A (rank 10), TNFAIP3, and its partner TNIP1 (rank 13 and 24, respectively) inhibit TCR-induced NFkB signaling, a critical survival and growth signal for activated CD8+ T cells (Düwel et al., 2009; Ge et al., 2017).”
From Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function (2018) · cites this paper as Düwel et al., 2009
Citations
Cites
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L., et al. (2004) · Nature · doi:10.1038/nature02794 · Cited by 1,856
PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes
Sun, Z., Arendt, C. W., Ellmeier, W., Schaeffer, E. M., Sunshine, M. J., Gandhi, L., Annes, J., Petrzilka, D., Kupfer, A., Schwartzberg, P. L., et al. (2000) · Nature · doi:10.1038/35006090 · Cited by 892 · cited 1×
“In T cells, activation of the atypical protein kinase C (PKC) has been shown to provide a critical link between TCR/ CD28 proximal signaling events and the NF- B pathway (4).”
Sun, L., Deng, L., Ea, C.-K., Xia, Z.-P., & Chen, Z. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00236-9 · Cited by 699 · cited 2×
“Further, IKK ubiquitination has been implicated in IKK activation after T cell stimulation (17, 20) and might there-”
Ubiquitin Chain Editing Revealed by Polyubiquitin Linkage-Specific Antibodies
Newton, K., Matsumoto, M. L., Wertz, I. E., Kirkpatrick, D. S., Lill, J. R., Tan, J., Dugger, D., Gordon, N., Sidhu, S. S., Fellouse, F. A., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.039 · Cited by 555
Ruland, J., Duncan, G. S., Elia, A., del Barco Barrantes, I., Nguyen, L., Plyte, S., Millar, D. G., Bouchard, D., Wakeham, A., Ohashi, P. S., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00189-1 · Cited by 553
Self-citationBcl10 activates the NF-κB pathway through ubiquitination of NEMO
Zhou, H., Wertz, I., O'Rourke, K., Ultsch, M., Seshagiri, S., Eby, M., Xiao, W., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02273 · Cited by 527 · cited 2×
“Further, IKK ubiquitination has been implicated in IKK activation after T cell stimulation (17, 20) and might there-”
Coornaert, B., Baens, M., Heyninck, K., Bekaert, T., Haegman, M., Staal, J., Sun, L., Chen, Z. J., Marynen, P., & Beyaert, R. (2008) · Nature Immunology · doi:10.1038/ni1561 · Cited by 434 · cited 8×
“Interestingly, two recent reports have shown that Malt1 paracaspase activity is required for optimal IL-2 production and it was suggested that the paracaspase-dependent cleavage of A20 could be one explanation for this result (28, 29).”
Self-citationRequirement for Caspase-8 in NF-κB Activation by Antigen Receptor
Su, H., Bidère, N., Zheng, L., Cubre, A., Sakai, K., Dale, J., Salmena, L., Hakem, R., Straus, S., & Lenardo, M. (2005) · Science · doi:10.1126/science.1104765 · Cited by 429 · cited 1×
“In addition, association of PDK1 and Caspase8 to the PKC -CBM signaling module has been shown to facilitate TCR-induced NF- B activation (12, 13).”
Differential Requirement for Malt1 in T and B Cell Antigen Receptor Signaling
Ruland, J., Duncan, G. S., Wakeham, A., & Mak, T. W. (2003) · Immunity · doi:10.1016/s1074-7613(03)00293-0 · Cited by 390
Self-citation
Cited by
Items 101–200 of 234
Deubiquitinases in hematological malignancies
Lei, H., Wang, J., Hu, J., Zhu, Q., & Wu, Y. (2021) · Biomarker Research · doi:10.1186/s40364-021-00320-w · Cited by 45
Rajamäki, K., Keskitalo, S., Seppänen, M. R. J., Kuismin, O., Vähäsalo, P., Trotta, L., Väänänen, A., Glumoff, V., Keskitalo, P. L., Kaarteenaho, R. L., et al. (2018) · RMD Open · doi:10.1136/rmdopen-2018-000740 · Cited by 35
MALT1 as a promising target to treat lymphoma and other diseases related to MALT1 anomalies
Liang, X., Cao, Y.-C., Li, C., Yu, H., Yang, C., & Liu, H. (2021) · Medicinal Research Reviews · doi:10.1002/med.21799 · Cited by 35
“A20 catalyzes the detachment of lysine (K) 63‐linked polyubiquitin chains on MALT1 and TRAF6.(69) The de‐ubiquitination activity of A20 is mediated by multiple adaptor proteins, such as the A20‐binding inhibitor of NF‐κB 1/2/3 (ABIN‐1/2/3) and the TAX‐1 binding protein‐1 (TAX1BP1).”
BackgroundInfluentialRegulation of inflammatory and antiviral signaling by A20
Parvatiyar, K., & Harhaj, E. W. (2010) · Microbes and Infection · doi:10.1016/j.micinf.2010.11.003 · Cited by 36
“A20 also undergoes proteasomal degradation at early times upon antigen receptor signaling, but is induced at later times in a negative feedback loop and targets polyubiquitinated MALT1 for deubiquitination which attenuates IKK and NF-κB activation [42].”
BackgroundDysfunction of the ubiquitin-proteasome system in atherosclerotic cardiovascular disease.
Wang, F., Lerman, A., & Herrmann, J. (2015) · Europe PMC (PubMed Central) · Cited by 36
Negative regulation of NF-κB signaling in T lymphocytes by the ubiquitin-specific protease USP34
Poalas, K., Hatchi, E. M., Cordeiro, N., Dubois, S. M., Leclair, H. M., Leveau, C., Alexia, C., Gavard, J., Vázquez, A., & Bidère, N. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-25 · Cited by 35
“In contrast to CYLD and A20, which target apical signaling [18,20], USP34 rather seems to function downstream of the IKK complex.”
InfluentialMALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor Cells
Gehring, T., Erdmann, T., Rahm, M., Graß, C., Flatley, A., O’Neill, T. J., Woods, S., Meininger, I., Karayel, Ö., Kutzner, K., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.040 · Cited by 33
Self-citationDoherty, R., Whiston, R., Cormican, P., Finlay, E. K., Couldrey, C., Brady, C., O’Farrelly, C., & Meade, K. G. (2016) · Scientific Reports · doi:10.1038/srep31014 · Cited by 29
A20 and ABIN-1 cooperate in balancing CBM complex-triggered NF-κB signaling in activated T cells
Yin, H., Karayel, Ö., Chao, Y.-Y., Seeholzer, T., Hamp, I., Plettenburg, O., Gehring, T., Zielinski, C. E., Mann, M., & Krappmann, D. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04154-z · Cited by 29
Self-citationTCR signaling to NF-κB and mTORC1: Expanding roles of the CARMA1 complex
Shi, J., & Sun, S. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.07.024 · Cited by 34
“Incubation of cells with a cell-permeable peptide inhibitor of MALT1 does not inhibit activation of IKK or JNK, although it impairs the activation of NF-κB transcriptional activity (Duwel et al., 2009; Rebeaud et al., 2008).”
BackgroundMalt1 and cIAP2–Malt1 as effectors of NF-κB activation: Kissing cousins or distant relatives?
Kingeter, L. M., & Schaefer, B. C. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.09.033 · Cited by 30
Control of NF-κB activation by the COP9 signalosome
Schweitzer, K., & Naumann, M. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380156 · Cited by 29
Moreno‐García, M. E., Sommer, K., Haftmann, C., Sontheimer, C., Andrews, S. F., & Rawlings, D. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902438 · Cited by 28
Molecular Pathways: Targeting MALT1 Paracaspase Activity in Lymphoma
Fontán, L., & Melnick, A. M. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3869 · Cited by 29
A20—A Bipartite Ubiquitin Editing Enzyme with Immunoregulatory Potential
Wertz, I. E., & Dixit, V. M. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-0398-6_1 · Cited by 30
Genome-wide association studies in multiple sclerosis: lessons and future prospects
Kemppinen, A., Sawcer, S. J., & Compston, A. (2011) · Briefings in Functional Genomics · doi:10.1093/bfgp/elr004 · Cited by 34
Jiang, X., Tian, H., Fan, Y., Chen, J., Song, Y., Wang, S., Zhu, F., Guo, C. H., Zhang, L., & Shi, Y. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00500-12 · Cited by 26
MicroRNA-873 Inhibits Morphine-Induced Macrophage Apoptosis by Elevating A20 Expression
Li, M., Yu, J.-H., Yu, S., Chi, Y.-Y., & Xiang, Y.-B. (2015) · Pain Medicine · doi:10.1111/pme.12784 · Cited by 27
A20 and CYLD Do Not Share Significant Overlapping Functions during B Cell Development and Activation
Chu, Y., Soberon, V., Glockner, L., Beyaert, R., Massoumi, R., Loo, G., Krappmann, D., & Schmidt‐Supprian, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200396 · Cited by 24
Self-citationIdentification of Immune-Responsive Gene 1 (IRG1) as a Target of A20
Quickelberghe, E. V., Martens, A., Goeminne, L. J. E., Clement, L., Loo, G., & Gevaert, K. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00139 · Cited by 28
ABIN-2, of the TPL-2 Signaling Complex, Modulates Mammalian Inflammation
Webb, L. V., Ventura, S., & Ley, S. C. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.07.001 · Cited by 24
Advances in the Study of the Ubiquitin-Editing Enzyme A20
Bai, W., Huo, S., Li, J., & Shao, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.845262 · Cited by 29
Knudson, K. M., Hamilton, S. E., Daniëls, M. A., Jameson, S. C., & Teixeiro, E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300905 · Cited by 22
Chen, M., Ding, Z., Zhang, F., Shen, H., Zhu, L., Yang, H., & Chen, S. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.111982 · Cited by 23
Dumont, C., Sivars, U., Andreasson, T., Odqvist, L., Mattsson, J., DeMicco, A., Pardali, K., Johansson, G., Yrlid, L., Cox, R. J., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0222548 · Cited by 22
MALT1 substrate cleavage: what is it good for?
Moud, B. N., Ober, F., O’Neill, T. J., & Krappmann, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1412347 · Cited by 25
“A20 has been coined a ubiquitin editing enzyme, because the N-terminal ovarian tumor (OTU) domain preferably hydrolyzes K48-and K63-linked ubiquitin chains, and the C-terminal zinc fi nger (ZnF) region, speci fi cally ZnF4 and ZnF7, facilitate ubiquitin-conjugation by associating with K63-and M1-linked ubiquitin chains,…”
BackgroundInfluentialSelf-citationMeng, Z., Xu, R., Xie, L., Wu, Y., He, Q., Gao, P., He, X., Chen, Q., Xie, Q., Zhang, J., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100811 · Cited by 24
Wei, F., Jiang, Z., Sun, H., Pu, J., Sun, Y., Wang, M., Tong, Q., Bi, Y., Ma, X., Gao, G. F., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008321 · Cited by 21
Low TNFAIP3 expression in psoriatic skin promotes disease susceptibility and severity
Sahloul, N. Y., Mostafa, M. S., Madkour, L. A. E.-F., & Salama, D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217352 · Cited by 23
Interplay between BCL10, MALT1 and IκBα during T-cell-receptor-mediated NFκB activation
Carvalho, G., Guelte, A. L., Demian, C., Vázquez, A., Gavard, J., & Bidère, N. (2010) · Journal of Cell Science · doi:10.1242/jcs.069476 · Cited by 26
“Jo ur na l o f C el l S ci en ce MALT1 at the CBM level to ensure IKK fine-tuning (Duwel et al., 2009), other DUBs are probably involved downstream of IB.”
BackgroundThe role of A20 in the pathogenesis of lymphocytic malignancy
Zhang, F., Yang, L., & Li, Y. (2012) · Cancer Cell International · doi:10.1186/1475-2867-12-44 · Cited by 22
“The regulation of NF-‐κB signaling as it relates to A20-mediated ubiquitylation in T cells is diagramed in Figure 1 [6,24-27].”
BackgroundThys, A., Douanne, T., & Bidère, N. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00498 · Cited by 27
4-1BB-encoding CAR causes cell death via sequestration of the ubiquitin-modifying enzyme A20
Dou, Z., Bonacci, T., Shou, P., Landoni, E., Woodcock, M. G., Sun, C., Savoldo, B., Herring, L. E., Emanuele, M. J., Song, F., et al. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01198-y · Cited by 21
“…pathway, a key regulator of cell survival [31 – 34], can be associated with cell death in 4-1BB costimulated CAR-T cells, we focused on the evidence that CoIP-LC-MS/MS showed two downstream negative regulators of the NF-κ B signaling - A20 and TNIP1 [35] - almost exclusively identi fi ed in the 19.”
BackgroundMethodInfluentialTNFα-Signaling Modulates the Kinase Activity of Human Effector Treg and Regulates IL-17A Expression
Urbano, P. C. M., He, X., van Heeswijk, B., Filho, O. P. D. S., Tijssen, H. J., Smeets, R. L., Joosten, I., & Koenen, H. J. P. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03047 · Cited by 24
The deubiquitinase A20 in immunopathology of autoimmune diseases
Majumdar, I., & Paul, J. (2014) · Autoimmunity · doi:10.3109/08916934.2014.900756 · Cited by 22
“A20 is also regulated by proteasome, since inhibition of proteasome partially impaired A20 degradation [27].”
BackgroundInfluentialAlternative Expression Pattern of MALT1-A20-NF- κ B in Patients with Rheumatoid Arthritis
Wang, X., Zhu, L., Liao, Z., Zhang, F., Xu, L., Xu, Y., Chen, S., Yang, L., Zhou, Y., & Li, Y. (2014) · Journal of Immunology Research · doi:10.1155/2014/492872 · Cited by 21
Sorrentino, A., Menevse, A. N., Michels, T., Volpin, V., Durst, F. C., Sax, J., Xydia, M., Hussein, A., Stamova, S., Spoerl, S., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004258 · Cited by 24
Identification of the NF-κB inhibitor A20 as a key regulator for human adipogenesis
Dorronsoro, A., Lang, V., Jakobsson, E., Ferrin, I., Salcedo, J. M., Fernández‐Rueda, J., Fechter, K., Rodriguez, M. S., & Trigueros, C. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.494 · Cited by 20
Molecular basis for specificity of the Met1-linked polyubiquitin signal
Elliott, P. R. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160227 · Cited by 24
Li, X., Wang, C., Wang, L., Huang, R., Li, W.-C., Wang, X., Wong, S. S. W., Cai, Z., Leung, K. C., & Jin, L. (2022) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2022.01.091 · Cited by 19
A20 is a regulator of necroptosis
Gurung, P., Man, S. M., & Kanneganti, T. (2015) · Nature Immunology · doi:10.1038/ni.3174 · Cited by 19
Allosteric activation of MALT1 by its ubiquitin-binding Ig3 domain
Schairer, R., Hall, G., Zhang, M., Cowan, R. H., Baravalle, R., Muskett, F. W., Coombs, P. J., Mpamhanga, C., Hale, L. R., SAXTY, B. A., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912681117 · Cited by 18
“To identify key ubiquitin residues involved in the binding to MALT1, we monitored differences in the 15 N/ 1 H HSQC spectrum of uniformly labelled ubiquitin (1-76) induced by the addition of MALT1 (Fig.”
BackgroundTargeting B-cell lymphomas with inhibitors of the MALT1 paracaspase
Hailfinger, S., Lenz, G., & Thome, M. (2014) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2014.09.025 · Cited by 18
Role of the HTLV-1 viral factors in the induction of apoptosis
Karimi, M. H., Mohammadi, H., Hemmatzadeh, M., Mohammadi, A., Rafatpanah, H., & Baradaran, B. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.034 · Cited by 19
Saxena, S., Lokhande, H. A., Gombolay, G. Y., Raheja, R., Rooney, T., & Chitnis, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-69182-w · Cited by 23
Aghajani, M., Faghihi, M., Imani, A., Mahdavi, M. R. V., Shakoori, A., Rastegar, T., Parsa, H., Mehrabi, S., Moradi, F., & Moghaddam, E. K. (2017) · Chronobiology International · doi:10.1080/07420528.2017.1281823 · Cited by 19
“DUBs such as A20 can conversely remove ubiquitin chains from cellular proteins and protect the infarcted heart against maladaptive remodeling, progressive decompensation and myocardial hypertrophy since they inhibit NF-κB signaling (Düwel et al., 2009).”
BackgroundPost-translational modification of MALT1 and its role in B cell- and T cell-related diseases
Zhang, Y., Peng, J., & Luo, X. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114977 · Cited by 20
Ubiquitylation as a Rheostat for TCR Signaling: From Targeted Approaches Toward Global Profiling
O’Leary, C. E., Lewis, E. L., & Oliver, P. M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00618 · Cited by 17
“Instead, A20 is constitutively expressed in mature resting T cells but is immediately down-regulated following T cell activation (171, 172).”
BackgroundMALT1 Inhibitors and Degraders: Strategies for NF-κB-Driven Malignancies
Zhang, R., Wang, Z., Zhang, M., Wang, Y.-F., Zhou, S.-L., Xu, J.-L., Lin, W., Ji, T.-R., Chen, Y., Lu, T., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02873 · Cited by 17
Mechanistic impact of oligomer poisoning by dominant-negative CARD11 variants
Bedsaul-Fryer, J. R., Shah, N., Hutcherson, S. M., & Pomerantz, J. L. (2022) · iScience · doi:10.1016/j.isci.2022.103810 · Cited by 15
“Extensive studies have shown that MALT1 is ubiquitinylated and phosphorylated during signaling, in part by the E3 ligase TRAF6 and the kinase CK1a, and that these modifications are required for optimal antigen receptor signaling (Duwel et al., 2009; Gehring et al., 2019; Oeckinghaus et al., 2007).”
BackgroundInfluentialChen, Q., Pang, M., Ye, X.-H., Yang, G., & Chen, L. (2018) · Parasites & Vectors · doi:10.1186/s13071-018-2837-1 · Cited by 15
Mirc11Disrupts Inflammatory but Not Cytotoxic Responses of NK Cells
Nanbakhsh, A., Srinivasamani, A., Holzhauer, S., Riese, M. J., Zheng, Y., Wang, D., Burns, R., Reimer, M. H., Rao, S., Lemke, A., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0934 · Cited by 15
Oikawa, D., Hatanaka, N., Suzuki, T., & Tokunaga, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.601926 · Cited by 18
“Subsequently, A20, a DUB, removes the K63-ubiquitin chain from MALT1 and thus downregulates the NF-kB activation pathway (49).”
BackgroundDoes Antigen Masking by Ubiquitin Chains Protect from the Development of Autoimmune Diseases?
Weil, R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00262 · Cited by 15
“It is also important to consider that in lymphocytes, A20 is constitutively expressed to prevent uncontrolled activation of NF-κB and its proteasomal degradation or its cleavage by the paracaspase MALT1 impairs its inhibitory function to allow optimal NF-κB activation as exemplified by the increased antigen-mediated N…”
BackgroundL-CBM signaling in lymphocyte development and function
Hara, Iizasa, E., Nakaya, & Yoshida (2010) · Journal of Blood Medicine · doi:10.2147/jbm.s9772 · Cited by 13
“Duwel et al have recently reported that A20 catalyzes the removal of the K63-linked ubiquitin chains attached to MALT1 and therefore regulates duration and strength of IKK activity (Figure 4).(58)”
BackgroundHu, J., Yi, S., Wang, C., Zhang, Y., Tang, J., Huang, X., Yang, L., Yang, J., & Li, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.603939 · Cited by 12
Zheng, H., Wang, X., Ma, Y., Xu, B., Chen, S., Yang, L., Wu, X., Przybylski, G. K., Huang, S., Ye, T.-Z., et al. (2013) · DNA and Cell Biology · doi:10.1089/dna.2013.2199 · Cited by 12
“However, this result is in contrast with the finding that MALT1 mediated the rapid proteolytic cleavage and inactivation of A20 after TCR stimulation (Coornaert et al., 2008; Duwel et al., 2009).”
Ubiquitination in host immune response to human papillomavirus infection
Zhou, Q., Zhu, K., & Cheng, H. (2011) · Archives of Dermatological Research · doi:10.1007/s00403-011-1141-0 · Cited by 13
Functional Characterization of Zebrafish (Danio rerio) Bcl10
Mazzone, P., Scudiero, I., Ferravante, A., Paolucci, M., D’Andrea, L. E., Varricchio, E., Telesio, G., Maio, C. D., Pizzulo, M., Zotti, T., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122365 · Cited by 11
“As for hBCL10 [25, 37], zBcl10-induced NF-κB activation requires ubiquitination(s) events, since NF-κB activation is completely abrogated following co-expression of A20 de-ubiquitinase (Fig.”
BackgroundUbiquitin Conjugation and Deconjugation in NF-κB Signaling
Düwel, M., Hadian, K., & Krappmann, D. (2010) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4419-6676-6_7 · Cited by 11
Self-citationLiang, X., Sun, C., Li, C., Yu, H., Wei, X., Liu, X., Bao, W., Shi, Y., Sun, X., Khamrakulov, M., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00466 · Cited by 11
Functional implications of the CpG island methylation in the pathogenesis of celiac disease
Ghosh, S., Khetarpal, P., & Senapati, S. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07585-w · Cited by 14
An anti-inflammatory role of A20 zinc finger protein during trauma combined with endotoxin challenge
Liu, B., Jiang, D., Ou, Y., Hu, Z., Jiang, J., & Lei, X. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.06.031 · Cited by 11
Liao, S.-C., Hsu, H.-W., Chuang, K.-L., Huang, Z.-Y., Lin, K., Hsu, W., Chang, K.-H., Huang, C. F., & Su, C. (2019) · Nutrients · doi:10.3390/nu11061397 · Cited by 11
Dissection of Signaling in Inflammation: Three Novel Inflammatory Regulators
Berger, T., Saunders, M. E., & Mak, T. W. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020107 · Cited by 11
“The ubiquitination and subsequent proteasomal degradation of IkB is triggered by phosphorylation of its IkBa subunit, an event mediated by activation of the IkB kinase (IKK) complex.”
BackgroundInfluentialMistuned NF-κB signaling in lymphocytes: lessons from relevant inborn errors of immunity
Dabbah‐Krancher, G., & Snow, A. L. (2023) · Clinical & Experimental Immunology · doi:10.1093/cei/uxad006 · Cited by 14
Preserving immune homeostasis with A20
Razani, B., Malynn, B. A., & Ma, A. I. (2020) · Advances in immunology · doi:10.1016/bs.ai.2020.10.001 · Cited by 9
Dissection of Signaling in Inflammation: Three Novel Inflammatory Regulators
Berger, T., Saunders, M. E., & Mak, T. W. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.78.020107 · Cited by 10
Fan, Y., Zhang, Y., Sun, Y., Wang, N., Xiao, X.-Y., & Wang, K. (2016) · Oncotarget · doi:10.18632/oncotarget.11993 · Cited by 9
“Besides, A20 has the capacity to suppress T cell activation and limit T cell receptor signaling to NF-κB by cleaving Malt1 ubiquitin chains [12].”
BackgroundThe latest developments in synthetic peptides with immunoregulatory activities
Zhou, C., Lu, R., Lin, G., & Yao, Z. (2010) · Peptides · doi:10.1016/j.peptides.2010.10.019 · Cited by 9
CARMA3: A potential therapeutic target in non-cancer diseases
Gui, Z., Zhang, Y., Zhang, A., Xia, W., & Jia, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1057980 · Cited by 10
Wang, Z., Zhang, Z., Yuan, J., & LI, L. (2015) · Biomedical Reports · doi:10.3892/br.2015.486 · Cited by 9
A20 reduces lipid storage and inflammation in hypertrophic adipocytes via p38 and Akt signaling
Ai, L., Wang, X., Chen, Z., Lin, Q., Su, D., Xu, Q., Wu, C. W., Jiang, X., Xu, A., & Fan, Z. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2768-0 · Cited by 9
Mechanisms underlying resistance to CAR-T cell therapy and strategies for enhancement
Wu, A., Zhang, T., Yu, H., Cao, Y., Zhang, R., Shao, R., Liu, B., Chen, L., Xu, K., Chen, W., et al. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.04.002 · Cited by 9
Шевелева, О. Н., Protasova, E., Nenasheva, T. A., Butorina, N. N., Melnikova, V. I., Gerasimova, T., Sakovnich, O., Kurinov, A. M., Grigor’eva, E. V., Medvedev, S. P., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612868 · Cited by 8
MALT1 protease: equilibrating immunity versus tolerance
Bertossi, A., & Krappmann, D. (2014) · The EMBO Journal · doi:10.15252/embj.201490217 · Cited by 8
“Pharmacological inhibition and genetic inactivation revealed that even though MALT1 proteolytic activity is dispensable for canonical NF-j B signaling, it is required for optimal T-cell activation (Rebeaud et al , 2008; Du¨wel et al , 2009).”
Self-citationSomatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunity
Mukohara, F., Iwata, K., Ishino, T., Inozume, T., Nagasaki, J., Ueda, Y., Suzawa, K., Ueno, T., Ikeda, H., Kawase, K., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2320189121 · Cited by 9
Dabbah‐Krancher, G., Ruchinskas, A. J., Kallarakal, M. A., Lee, K. P., Bauman, B. M., Epstein, B. E., Yin, H., Krappmann, D., Schaefer, B. C., & Snow, A. L. (2024) · European Journal of Immunology · doi:10.1002/eji.202451245 · Cited by 8
Self-citationMechanism study of ubiquitination in T cell development and autoimmune disease
Yu, H., Yang, W., Cao, M., Lei, Q., Yuan, R., He, X., Cui, Y., Chen, X., Su, X., Zhuo, H., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1359933 · Cited by 10
Zhang, C., Zhu, K., Liu, H.-C., Quan, C., Liu, Z., Li, S.-J., Zhu, C.-Y., Li, K.-S., & Fan, Y.-M. (2014) · Clinical and Experimental Dermatology · doi:10.1111/ced.12536 · Cited by 8
Cheong, H. C., Cheok, Y. Y., Chan, Y. T., Tang, T. F., Sulaiman, S., Looi, C. Y., Gupta, R., Arulanandam, B. P., Chang, L., & Wong, W. F. (2023) · BMC Microbiology · doi:10.1186/s12866-023-02802-3 · Cited by 8
“TNFAIP3 codes for the ubiquitin-modifying enzyme A20 that possesses an anti-inflammatory function by suppressing the activation of NF-κB [19, 20].”
BackgroundSakai, Y., Uchida, K., & Nakayama, H. (2011) · Inflammation Research · doi:10.1007/s00011-011-0406-6 · Cited by 7
Layzell, S., Barbarulo, A., Loo, G., Beyaert, R., & Seddon, B. P. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01383-6 · Cited by 12
Qian, T., Chen, Y., Shi, X., Li, J., Hao, F., & Zhang, D. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3612 · Cited by 6
“TNFAIP3 is an inhibitor of inflammation, and the deubiquitination of TNFAIP3 in T cells negatively regulates NF-κ B, which is crucial for inflammatory and immune responses (37).”
Geles, K., Vlachavas, E., Papadodima, O., Pilalis, E. D., Vorgias, C. E., Georgakilas, A. G., & Chatziioannou, A. A. (2017) · Cancers · doi:10.3390/cancers9120160 · Cited by 6
“The latter are involved in immunoregulatory processes, polyamine metabolism [42–44], the inhibition of NF-kappa B [30], proliferation, and wound healing [45].”
BackgroundImmune Regulation by Ubiquitin Tagging as Checkpoint Code
Zeng, P., Ma, J., Yang, R., & Liu, Y. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_64 · Cited by 7
Bowman, C., Stibor, D., Sun, X., Shimizu, H., Yamashita, E., Lenci, N., Advincula, R., Kim, M. C., Turnbaugh, J. A., Sun, Y., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci187499 · Cited by 7
Li, Y., Hong, Y., Zhang, J., & Xu, S. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118372 · Cited by 5
Cammann, C., Israel, N., Slevogt, H., & Seifert, U. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073424 · Cited by 4
“As a counter-regulation, the DUB A20 is able to remove K63-polyubiquitin chains from the CBM complex protein MALT1, thereby downmodulating TCR-induced NF-κB activity [70].”
BackgroundPomerantz, J. L. (2020) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100775 · Cited by 4
“, 2010) and the action of inhibitory A20 (Coornaert et al., 2008; Duwel et al., 2009), GAKIN (Lamason et al.”
BackgroundInfluentialDetection and Measurement of Paracaspase MALT1 Activity
Hailfinger, S., Pelzer, C., & Thome, M. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0357-3_11 · Cited by 4
“The scaffold function of MALT1 is required for IKK-mediated NF-kB activation [19, 20].”
BackgroundTargeting toll-like receptors: unveiling potential therapeutic strategies for deep vein thrombosis
Shao, W., Wang, Z., Wu, J., Guo, T., & Mo, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1579113 · Cited by 4
“For example, Düwel et al. (160) discovered that A20 prevents the prolonged activation of NF-k B through the removal of K63-linked ubiquitin chains from Malt1, an action essential for the correct functioning of immune cells.”
The deubiquitinase USP17LA negatively regulates T-cell activation and attenuates anti-tumor immunity
Zhang, H., Guo, Z., Wei, G., Yi, J., Wang, Z., Zhang, Y., Zhao, H., Ren, T., Wang, Y., Kuang, J., et al. (2025) · EMBO Reports · doi:10.1038/s44319-025-00584-5 · Cited by 5
“Besides, A20, OTUB1, and OTUD2B were reported to be associated with T-cell activation (Düwel et al, 2009; Hu et al, 2016; Zhou et al, 2019).”
The Function of Ubiquitination in T-Cell Development
Peng, Z., Zhang, H., & Hu, H. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-97-7288-9_10 · Cited by 3
Inoue, K., Yasuda, T., Baba, Y., Yamamoto, T. S., Kurosaki, T., & Shinohara, H. (2023) · Genes to Cells · doi:10.1111/gtc.13022 · Cited by 3
TNFAIP3 (tumor necrosis factor, alpha-induced protein 3)
Rasi, S., Rossi, D., & Gaïdano, G. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/44762 · Cited by 2
Villalba, M., Canales, N., Maldonado, N., Carola Otth, L., Fredericksen, F., Garcés, P., Stepke, C., Arriagada, V., & Olavarría, V. H. (2017) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2017.07.019 · Cited by 3
“This factor maintains immune homeostasis in the cell through deubiquitinating 36 enzyme activity in the N-terminal ovarian tumor domain and E3 ubiquitin ligase activity in 37 the C-terminal zinc finger-containing domain (Boone et al., 2004; Du¨wel et al., 2009).”
BackgroundLUBAC modulates CBM complex functions downstream of TRAF6 in T cells
Graß, C., Ober, F., Sixt, C., Moud, B. N., Antoshkina, I. V., Eberstadt, F., Puhach, A., Avar, G., Keßler, A., O’Neill, T. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65879-6 · Cited by 3
Self-citationA20 as a Potential Therapeutic Target for COVID‐19
Wu, Y., Li, H., Li, R., Li, J., Zhao, Q., & Shao, B. (2025) · Immunity Inflammation and Disease · doi:10.1002/iid3.70127 · Cited by 2
Functional characterization of a BCL10 isoform in the rainbow troutOncorhynchus mykiss
Mazzone, P., Scudiero, I., Coccia, E., Ferravante, A., Paolucci, M., D’Andrea, E. L., Varricchio, E., Pizzulo, M., Reale, C., Zotti, T., et al. (2015) · FEBS Open Bio · doi:10.1016/j.fob.2015.01.007 · Cited by 2
Metadata
- Authors
- Düwel, M., Welteke, V., Oeckinghaus, A., Baens, M., Kloo, B., Ferch, U., Darnay, B. G., Ruland, J., Marynen, P., & Krappmann, D.
- Affiliations
- Helmholtz Munich (DE)
- Vlaams Instituut voor Biotechnologie (BE)
- TUM Klinikum (DE)
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Welteke, Verena
- Oeckinghaus, Andrea
- Kloo, Bernhard
- Krappmann, Daniel
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-06
- Volume
- 182
- Issue
- 12
- Pages
- 7718-7728
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1955888505
- Cited by
- 233
- References
- 40
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 8 · 2023: 9 · 2022: 11 · 2021: 11 · 2020: 12 · 2019: 10 · 2018: 16 · 2017: 13 · 2016: 18 · 2015: 21 · 2014: 17 · 2013: 20 · 2012: 15
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- Funders
- Silence Therapeutics
- Genentech
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- A20, MALT1, T cell receptor signaling, NF-κB, IKK activation, K63-linked ubiquitin, deubiquitination, paracaspase, CD28 costimulation, proteasomal degradation, IL-2 production, T cell activation
- MeSH terms
- Tumor Necrosis Factor alpha-Induced Protein 3, Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein, Cell Line, DNA-Binding Proteins, Enzyme Activation, Humans, Neoplasm Proteins, Nuclear Proteins, Protein Binding, Receptors, Antigen, T-Cell, Signal Transduction, Down-Regulation, NF-kappa B, Caspases, Ubiquitin, RNA, Small Interfering, Proteasome Endopeptidase Complex, Intracellular Signaling Peptides and Proteins, I-kappa B Kinase, CARD Signaling Adaptor Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.